Suppr超能文献

COVID-19 和国家死因统计中的选择问题。

COVID-19 and the selection problem in national cause-of-death statistics.

机构信息

Department of Philosophy, Stockholm University, 106 91, Stockholm, Sweden.

出版信息

Hist Philos Life Sci. 2021 May 25;43(2):72. doi: 10.1007/s40656-021-00420-8.

Abstract

The World Health Organization has issued international instructions for certification and classification (coding) of the coronavirus disease (COVID-19) as cause of death. Central to these instructions is the selection of the underlying cause of death for a public health preventive purpose. This article focuses on two rules for this selection: (1) that a death due to COVID-19 should be counted independently of pre-existing conditions that are suspected of triggering a severe course of COVID-19 and (2) that COVID-19 should not be considered as due to anything else. The article argues that observance of the first rule may not always lead to an optimal selection from a preventive point of view and that in the future the ascertainment of an animal source of the coronavirus (SARS-CoV-2) would make it possible to reconceptualize 'COVID-19' and create a zoonotic classification code by means of which a factor of a greater preventive value could be selected than what is currently possible.

摘要

世界卫生组织发布了冠状病毒病(COVID-19)的国际认证和分类(编码)国际指导意见。这些指导意见的核心是为了公共卫生预防目的选择根本死因。本文重点介绍了两种选择规则:(1)因 COVID-19 导致的死亡应独立于疑似引发 COVID-19 严重病程的先前存在的病症进行计数;(2)COVID-19 不应归因于其他任何原因。文章认为,遵守第一条规则并不总是从预防角度出发进行最佳选择,而且未来,确定冠状病毒(SARS-CoV-2)的动物来源将使人们有可能重新概念化“COVID-19”,并创建一个人畜共患病分类代码,通过该代码可以选择比目前更具预防价值的因素。

相似文献

1
COVID-19 and the selection problem in national cause-of-death statistics.
Hist Philos Life Sci. 2021 May 25;43(2):72. doi: 10.1007/s40656-021-00420-8.
2
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
3
Human and novel coronavirus infections in children: a review.
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.
Cochrane Database Syst Rev. 2020 Jul 7;7(7):CD013665. doi: 10.1002/14651858.CD013665.
5
Universal screening for SARS-CoV-2 infection: a rapid review.
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
7
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
8
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
9
SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus.
Travel Med Infect Dis. 2020 Sep-Oct;37:101830. doi: 10.1016/j.tmaid.2020.101830. Epub 2020 Aug 2.
10
COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study.
PLoS Med. 2022 Nov 8;19(11):e1004118. doi: 10.1371/journal.pmed.1004118. eCollection 2022 Nov.

本文引用的文献

1
The immuno-oncological challenge of COVID-19.
Nat Cancer. 2020 Oct;1(10):946-964. doi: 10.1038/s43018-020-00122-3. Epub 2020 Oct 2.
2
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort.
Nat Cancer. 2020 Oct;1(10):965-975. doi: 10.1038/s43018-020-00120-5. Epub 2020 Sep 22.
3
COVID-19 as the underlying cause of death: disentangling facts and values.
Hist Philos Life Sci. 2021 Jan 8;43(1):4. doi: 10.1007/s40656-020-00355-6.
4
Unraveling the Zoonotic Origin and Transmission of SARS-CoV-2.
Trends Ecol Evol. 2021 Mar;36(3):180-184. doi: 10.1016/j.tree.2020.12.002. Epub 2020 Dec 13.
5
Covid-19: risk factors for severe disease and death.
BMJ. 2020 Mar 26;368:m1198. doi: 10.1136/bmj.m1198.
6
Why is prevention so difficult and slow?
Scand J Soc Med. 1997 Sep;25(3):145-8. doi: 10.1177/140349489702500301.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验